T Repka
Impact in
- Hematology top 5%
- Iron Metabolism and Disorders
- Genetics top 5%
- Hemoglobinopathies and Related Disorders
Papers in ⓘ
- Genetics 11
- Hemoglobinopathies and Related Disorders 8
- Chronic Lymphocytic Leukemia Research 3
- Hematology 11
- Iron Metabolism and Disorders 7
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- RP Hebbel (3 shared papers)Jeffrey S. Miller (6 shared papers)Linda J. Burns (5 shared papers)Sarah Cooley (1 shared paper)Daniel J. Weisdorf (5 shared papers)Todd E. DeFor (4 shared papers)Bertram H. Lubin (1 shared paper)P Rouyer-Fessard (1 shared paper)
- Journals
- Blood (5 papers)Experimental Hematology (3 papers)Bone Marrow Transplantation (2 papers)Journal of Clinical Investigation (2 papers)Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (1 paper)
- Partner nations
- United StatesSwitzerlandVietnam
In The Last Decade
T Repka
18 papers receiving 934 citations
Peers
Comparison fields: 5 of 81
- Hematology 312
- Genetics 296
- Immunology 305
- Oncology 363
- Radiology, Nuclear Medicine and Imaging 154
Countries citing papers authored by T Repka
This map shows the geographic impact of T Repka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Repka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Repka more than expected).
Fields of papers citing papers by T Repka
This network shows the impact of papers produced by T Repka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Repka. The network helps show where T Repka may publish in the future.
Co-authors
The 25 scholars most cited alongside T Repka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 195 | |
| 2 | 1999 | 171 | |
| 3 | 1993 | 171 | |
| 4 | 1991 | 95 | |
| 5 | 1995 | 81 | |
| 6 | Trastuzumab and interleukin-2 in HER2-positive metastatic breast cancer: a pilot study. | 2003 | 66 |
| 7 | 1993 | 58 | |
| 8 | 2000 | 34 | |
| 9 | 2000 | 25 | |
| 10 | 2005 | 20 | |
| 11 | 1992 | 20 | |
| 12 | 2007 | 14 | |
| 13 | 2002 | 8 | |
| 14 | 2000 | 5 | |
| 15 | 1991 | 4 | |
| 16 | 1993 | 3 | |
| 17 | 1998 | 2 | |
| 18 | Reticulocytosis: defective reticulin degradation, a case report. | 1989 | 2 |
About T Repka
T Repka is a scholar working on Genetics, Hematology, Physiology, Oncology and Molecular Biology, having authored 18 papers that have together received 974 indexed citations. Recurring topics across this work include Hemoglobinopathies and Related Disorders (8 papers), Iron Metabolism and Disorders (7 papers), Erythrocyte Function and Pathophysiology (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Immune Cell Function and Interaction (3 papers), Heme Oxygenase-1 and Carbon Monoxide (3 papers) and Neonatal Health and Biochemistry (1 paper). The work is most often cited by research in Hematology (312 citations), Genetics (296 citations), Immunology (305 citations), Oncology (363 citations) and Radiology, Nuclear Medicine and Imaging (154 citations). T Repka has collaborated with scholars based in United States, Switzerland and Vietnam. Frequent co-authors include RP Hebbel, Jeffrey S. Miller, Linda J. Burns, Sarah Cooley, Daniel J. Weisdorf, Todd E. DeFor, Bertram H. Lubin, P Rouyer-Fessard, Yves Beuzard and Mark D. Scott. Their work appears in journals such as Blood, Experimental Hematology, Bone Marrow Transplantation, Journal of Clinical Investigation and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.